Ixinity
Payments companies reported to CMS as associated with Ixinity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ixinity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ixinity
These are the largest totals companies reported as associated with Ixinity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nataly Apollonsky | Philadelphia, PA | Pediatric Hematology-Oncology | $7,100.00 |
| Mindy Simpson | Chicago, IL | Pediatrics | $2,600.00 |
| Nina Hwang | Orange, CA | Pediatrics | $2,600.00 |
| Jordan Shavit | Ann Arbor, MI | Pediatric Hematology-Oncology | $2,600.00 |
| Shirley Abraham | Albuquerque, NM | Pediatric Hematology-Oncology | $2,600.00 |
| Joanna Davis | Miami, FL | Pediatrics | $2,600.00 |
| Shelley Crary | Little Rock, AR | Pediatric Hematology-Oncology | $2,600.00 |
| Daisy Cortes | Las Vegas, NV | Pediatric Hematology-Oncology | $149.27 |
| Dwight Generoso | Las Vegas, NV | Family | $78.63 |
| Jenny Gober Mcdaniel | Las Vegas, NV | Pediatric Hematology-Oncology | $70.64 |
Prescribed Ixinity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.